Michael Gladstone
InvestorPartner at Atlas Venture · Board director at Caldera Therapeutics, Inc. · Board director at Day One Biopharmaceuticals
Boston, Massachusetts
Writes $10M – $50M checks · typically $25M
About
Michael Gladstone is a partner at Atlas Venture, which he joined in 2012, and works on forming new therapeutics companies. Before Atlas, he worked at L.E.K. Consulting on business development and corporate strategy for biopharma clients, and earlier led HIV vaccine research in the Viral Pathogenesis department at Beth Israel Deaconess Medical Center. He holds an AB in biochemical sciences from Harvard College.
Contact· self-published, not guessed
Invests in
Biotech
Board director at Caldera Therapeutics, Inc.
Intro paths
In turn, Michael can intro founders to Caldera Therapeutics, Inc.'s investors below.
Caldera Therapeutics, Inc.'s investors · 8
Board director at Day One Biopharmaceuticals
Intro paths
In turn, Michael can intro founders to Day One Biopharmaceuticals's investors below.
Experience
- Atlas VenturePartnercurrent2020 — present
- Atlas VenturePrincipalcurrent2015 — presentCambridge, MA
- Atlas VentureAssociate2012 — 2014Boston
- L.E.K. ConsultingSenior Associate Consultant2009 — 2012Boston
- Eutropics PharmaceuticalsMLSC Fellow2009Boston
Deals · 1
Caldera Therapeutics, Inc.Board seat
via Atlas Venture · filed Jan 2026 · $37.5M raise
Attribution from SEC filings, press coverage, and firm rosters.
Other disclosed investments
Board seats
Aiolos BioAkeroAvroBioCaldera TherapeuticsDay One BiopharmaceuticalsDay One BiopharmaceuticalsDeliniaDiagonal TherapeuticsEthyreal BioIFM Therapeutics LLCKailera TherapeuticsObsidian TherapeuticsPheon TherapeuticsReplimuneThird Harmonic BioVersanis BioXilio Therapeutics
Sources: the firm's website · SEC Form D filings.
Colleagues at Atlas Venture
Frequently asked questions
- Who is Michael Gladstone?
- Michael Gladstone is a partner at Atlas Venture, which he joined in 2012, and works on forming new therapeutics companies. Before Atlas, he worked at L.E.K. Consulting on business development and corporate strategy for biopharma clients, and earlier led HIV vaccine research in the Viral Pathogenesis department at Beth Israel Deaconess Medical Center. He holds an AB in biochemical sciences from Harvard College.
- Where does Michael Gladstone work?
- Michael Gladstone is Partner at Atlas Venture and Board director at Caldera Therapeutics, Inc. and Board director at Day One Biopharmaceuticals.
- What does Michael Gladstone invest in?
- Michael Gladstone invests in Biotech.
- What check size does Michael Gladstone write?
- Michael Gladstone typically writes checks of $10M – $50M.
- What boards does Michael Gladstone sit on?
- Michael Gladstone holds tracked board seats at Aiolos Bio, Akero, AvroBio, Caldera Therapeutics, Caldera Therapeutics, Inc., Day One Biopharmaceuticals, Day One Biopharmaceuticals, Delinia, Diagonal Therapeutics, Ethyreal Bio.
- Where did Michael Gladstone go to school?
- Michael Gladstone studied at Harvard University (BA, Biochemical Sciences).
Same school
Also attended Harvard University1,971
+ 1,965 more
Shared employers
Also worked at Atlas Venture56
+ 50 more
.jpg)
